Insights into the Mechanism of Ethionamide Resistance in <i>Mycobacterium tuberculosis</i> through an <i>in silico</i> Structural Evaluation of EthA and Mutants Identified in Clinical Isolates
Mutation in the ethionamide (ETH) activating enzyme, EthA, is the main factor determining resistance to this drug, used to treat TB patients infected with MDR and XDR <i>Mycobacterium tuberculosis</i> isolates. Many mutations in EthA of ETH resistant (ETH-R) isolates have been described...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Catalysts |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4344/10/5/543 |